Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FranceLEVO - Zimino® Registry: a French Registry Evaluating the Use of Levosimendan (Zimino®)

NCT04252404 is registered in ClinicalTrials.gov with Arcothova as lead sponsor.

NCT NCT04252404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04252404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FranceLEVO - Zimino® Registry: a French Registry Evaluating the Use of Levosimendan (Zimino®)
Lead sponsor
Arcothova
Phase
Observational
Overall status
Completed
Start date
February 3, 2020
Completion date
May 6, 2021
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure